SPHINX was shown to be more selective but similarly potent for SRPK1 compared to SRIN340, was shown to significantly downregulate VEGF165 expression, and inhibit tumor growth in an orthotopic mouse model of prostate cancer (87, 97). Here, SRPK1 is linked to neoplasm.